Observational studyDrug design, development and therapy2016

Reducing the trigger dose of recombinant hCG in high-responder patients attending an assisted reproductive technology program: an observational study.

Gian Mario Tiboni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.